Entrada Therapeutics, Inc. - Common Stock (NQ:TRDA)
Price and Volume
Detailed Quote| Volume | 176,341 |
| Open | 10.73 |
| Bid (Size) | 9.100 (100) |
| Ask (Size) | 11.60 (1,000) |
| Prev. Close | 10.58 |
| Today's Range | 10.31 - 10.73 |
| 52wk Range | 4.930 - 18.76 |
| Shares Outstanding | 33,197,018 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Beyond The Numbers: 4 Analysts Discuss Entrada Therapeutics Stock ↗
November 06, 2024
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
November 06, 2025
Entrada Therapeutics to Present at Upcoming Investor Conferences
October 28, 2025
Entrada (TRDA) Q2 Revenue Drops 98% ↗
August 06, 2025
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
November 05, 2024
Frequently Asked Questions
Is Entrada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Entrada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Entrada Therapeutics, Inc. - Common Stock trade on?
Entrada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Entrada Therapeutics, Inc. - Common Stock?
The ticker symbol for Entrada Therapeutics, Inc. - Common Stock is TRDA on the Nasdaq Stock Market
What is the current price of Entrada Therapeutics, Inc. - Common Stock?
The current price of Entrada Therapeutics, Inc. - Common Stock is 10.41
When was Entrada Therapeutics, Inc. - Common Stock last traded?
The last trade of Entrada Therapeutics, Inc. - Common Stock was at 12/26/25 04:00 PM ET
What is the market capitalization of Entrada Therapeutics, Inc. - Common Stock?
The market capitalization of Entrada Therapeutics, Inc. - Common Stock is 345.58M
How many shares of Entrada Therapeutics, Inc. - Common Stock are outstanding?
Entrada Therapeutics, Inc. - Common Stock has 346M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube